30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United Kingdom Pharmaceuticals

Indivior PLC (INDV)

Track

In the last 90 days, Indivior PLC saw a net insider selling of $4.78 million, with officers proposing significant sales totaling over $3.3 million. This contrasts with earlier buying activity in January and March. The stock has performed strongly, up 22.4% in 90 days, nearing its 52-week high.
Stock chart
Ticker: INDV Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Heidbreder Christian
Chief Scientific Officer
2 sales — total 200,000 USD
Planned sale 11 Jun 2026
Value US$1,510,158.06 | Price 482.96 | Shares 36,186
Proposed sale 11 Jun 2026
Value US$3,454,247.81 | Price 466.38 | Shares 10,540
Planned sale 8 Jun 2026
Value US$4,044,386.15 | Price 277.32 | Shares 93,310
Proposed sale 8 Jun 2026
Value US$4,385,989.91 | Price 86.66 | Shares 75,732
Proposed sale 8 Jun 2026
Value US$100,000.00 | Price 37.70 | Shares 1,000
Buy 13 Mar 2026
Value US$248.68 | Price 31.09 | Shares 8
Buy 9 Mar 2026
Value US$1,009.36 | Price 32.56 | Shares 31
Buy 6 Mar 2026
Value US$29,953.10 | Price 31.87 | Shares 940
Buy 5 Jan 2026
Value US$62,680.29 | Price 35.39 | Shares 1,771
Buy 5 Jan 2026
Value US$27,429.27 | Price 35.39 | Shares 775
Buy 5 Jan 2026
Value US$27,429.27 | Price 35.39 | Shares 775
Buy 5 Jan 2026
Value US$27,429.27 | Price 35.39 | Shares 775
Buy 5 Jan 2026
Value US$27,429.27 | Price 35.39 | Shares 775
Proposed sale 7 Nov 2025
Value US$3,731,762.50 | Price 30.65 | Shares 121,737
Proposed sale 8 Sep 2025
Value US$655,000.00 | Price 24.75 | Shares 26,463
Proposed sale 8 Sep 2025
Value US$4,593,150.74 | Price 24.97 | Shares 183,938
Proposed sale 4 Sep 2025
Value US$744,009.60 | Price 24.80 | Shares 30,000
Proposed sale 28 Aug 2025
Value US$1,278,178.00 | Price 24.43 | Shares 52,320
Buy 20 Dec 2024
Value US$251,022.00 | Price 11.73 | Shares 21,400
Buy 29 Jul 2024
Value US$9,822.43 | Price 12.67 | Shares 775
Buy 26 Jul 2024
Value US$24,595.73 | Price 12.78 | Shares 1,925
Through Timothy Thompson, a closely affiliated person
Buy 26 Jul 2024
Value US$24,595.73 | Price 12.78 | Shares 1,925
Buy 26 Jul 2024
Value US$9,977.70 | Price 12.63 | Shares 790
Buy 26 Jul 2024
Value US$97,397.25 | Price 12.75 | Shares 7,639
Buy 26 Jul 2024
Value US$59,279.44 | Price 12.71 | Shares 4,664
Buy 26 Jul 2024
Value US$9,613.24 | Price 12.65 | Shares 760
Buy 26 Jul 2024
Value £9.70 | Price 0.02 | Shares 500
Buy 26 Jul 2024
Value £9.72 | Price 0.01 | Shares 850
Buy 26 Jul 2024
Value £14,996.17 | Price 10.06 | Shares 1,490
Buy 9 May 2024
Value US$9,889.00 | Price 17.98 | Shares 550
Sale 18 Mar 2024
Value £170,577.33 | Price 16.17 | Shares 10,549
Proposed sale 15 Mar 2024
Value US$43,399.00 | Price 20.77 | Shares 2,090
Sale 15 Mar 2024
Value £253,899.36 | Price 16.44 | Shares 15,444
Sale 15 Mar 2024
Value £43,409.30 | Price 20.77 | Shares 2,090
Proposed sale 14 Mar 2024
Value US$313,231.00 | Price 20.75 | Shares 15,096
Sale 14 Mar 2024
Value £998,945.50 | Price 16.30 | Shares 61,285
Sale 14 Mar 2024
Value £1,486,625.20 | Price 16.30 | Shares 91,204
Sale 14 Mar 2024
Value £1,071,043.33 | Price 16.21 | Shares 66,073
Sale 14 Mar 2024
Value £313,242.00 | Price 20.75 | Shares 15,096
Proposed sale 14 Mar 2024
Value US$1,388,854.00 | Price 21.02 | Shares 66,073
Proposed sale 13 Mar 2024
Value US$132,362.00 | Price 21.06 | Shares 6,284
Sale 13 Mar 2024
Value US$132,341.04 | Price 21.06 | Shares 6,284
Sale 13 Mar 2024
Value £14,016.50 | Price 16.49 | Shares 850
Through Paul Hudson, a closely affiliated person
Sale 13 Mar 2024
Value £31,331.00 | Price 16.49 | Shares 1,900
Sale 6 Mar 2024
Value £516,600.00 | Price 17.22 | Shares 30,000
Sale 6 Mar 2024
Value £964,274.00 | Price 17.00 | Shares 56,722
Sale 5 Mar 2024
Value £1,464,908.08 | Price 17.06 | Shares 85,868
Sale 5 Mar 2024
Value £408,756.70 | Price 17.05 | Shares 23,974
Sale 5 Mar 2024
Value £972,547.35 | Price 17.23 | Shares 56,445
Sale 4 Mar 2024
Value £353,764.47 | Price 17.31 | Shares 20,437
Sale 4 Mar 2024
Value £320,541.25 | Price 17.35 | Shares 18,475
Sale 4 Mar 2024
Value £368,318.94 | Price 17.34 | Shares 21,241
Buy 20 Dec 2023
Value £20,724.27 | Price 11.89 | Shares 1,743
Buy 19 Dec 2023
Value £20,726.29 | Price 11.47 | Shares 1,807
Buy 20 Nov 2023
Value £35,775.00 | Price 13.50 | Shares 2,650
Buy 17 Nov 2023
Value £36,718.50 | Price 13.45 | Shares 2,730
Buy 17 Nov 2023
Value US$50,100.00 | Price 16.70 | Shares 3,000
Buy 17 Nov 2023
Value US$20,160.00 | Price 16.80 | Shares 1,200
Sale 5 May 2023
Value £1,727,000.00 | Price 15.70 | Shares 110,000
Sale 23 Mar 2023
Value £28,160.00 | Price 14.08 | Shares 2,000
Sale 14 Mar 2023
Value £3,542,529.52 | Price 14.78 | Shares 239,684
Sale 14 Mar 2023
Value £133,241.70 | Price 14.78 | Shares 9,015
Sale 14 Mar 2023
Value £2,877,946.82 | Price 14.78 | Shares 194,719
Sale 14 Mar 2023
Value £1,381,412.70 | Price 14.78 | Shares 93,465
Buy 6 Mar 2023
Value £19,529.77 | Price 15.02 | Shares 1,300
Buy 6 Mar 2023
Value £21,032.06 | Price 15.02 | Shares 1,400
Sale 14 Mar 2022
Value £427,757.24 | Price 2.71 | Shares 157,844
Sale 7 Mar 2022
Value £1,307,673.22 | Price 2.57 | Shares 508,229
Sale 7 Mar 2022
Value £1,465,511.33 | Price 2.57 | Shares 569,573
Sale 17 Feb 2022
Value £810,000.00 | Price 2.70 | Shares 300,000
Buy 10 Aug 2021
Value £58,186.80 | Price 1.62 | Shares 36,000
Buy 9 Aug 2021
Value £8,998.42 | Price 1.66 | Shares 5,424
Sale 6 Aug 2021
Value £195,012.00 | Price 1.63 | Shares 120,000
Through Scopia Capital Management LP, Scopia Management Inc., a closely affiliated person
Sale 5 Aug 2021
Value £112,244.09 | Price 1.66 | Shares 67,499
Through Scopia Capital Management LP, Scopia Management Inc., a closely affiliated person
Buy 4 Aug 2021
Value £50,024.64 | Price 1.71 | Shares 29,220
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-12 2026-06-11 PlS Planned sale
2.7
Heidbreder Christian

Chief Scientific Officer

Officer
36,186 -45.1%
482.96
US$1,510,158 		36,186 -45.1% 482.96 US$1,510,158
2026-06-11 2026-06-11 PrS Proposed sale
2.7
Heidbreder Christian

Officer

Officer
10,540
466.38
US$3,454,248 		10,540 466.38 US$3,454,248
2026-06-10 2026-06-08 PlS Planned sale
Preblick Ryan

Chief Financial Officer

Officer
93,310 +38.5%
277.32
US$4,044,386 		93,310 +38.5% 277.32 US$4,044,386
2026-06-08 2026-06-08 PrS Proposed sale
Preblick Ryan

Officer

Officer
1,000
37.70
US$100,000 		1,000 37.70 US$100,000
2026-06-08 2026-06-08 PrS Proposed sale
Preblick Ryan

Officer

Officer
1,000
37.70
US$100,000 		1,000 37.70 US$100,000
2026-03-13 2026-03-13 B Purchase
3.0
Ryan Barbara
Non-Executive Director
8 +0.1%
31.09
US$249 		8 +0.1% 31.09 US$249
2026-03-11 2026-03-09 B Purchase
3.0
Ryan Barbara
Non-Executive Director
31 +0.5%
32.56
US$1,009 		31 +0.5% 32.56 US$1,009
2026-03-11 2026-03-06 B Purchase
Kingsley Stuart A
Non-Executive Director
940 +20.2%
31.87
US$29,953 		940 +20.2% 31.87 US$29,953
2026-01-07 2026-01-05 B Purchase
1.5
Wheadon David E.
Non-Executive Director
1,771 +14.0%
35.39
US$62,680 		1,771 +14.0% 35.39 US$62,680
2026-01-07 2026-01-05 B Purchase
3.2
Stejbach Mark
Non-Executive Director
775 +4.8%
35.39
US$27,429 		775 +4.8% 35.39 US$27,429
2026-01-07 2026-01-05 B Purchase
3.0
Ryan Barbara
Non-Executive Director
775 +65.2%
35.39
US$27,429 		775 +65.2% 35.39 US$27,429
2026-01-07 2026-01-05 B Purchase
2.2
NINIVAGGI DANIEL A
Non-Executive Director
775 +4.8%
35.39
US$27,429 		775 +4.8% 35.39 US$27,429
2026-01-07 2026-01-05 B Purchase
2.3
Humphreys Keith
Non-Executive Director
775 +15.4%
35.39
US$27,429 		775 +15.4% 35.39 US$27,429
2025-11-07 2025-11-07 PrS Proposed sale
Cetani Cynthia C

Officer

Officer
121,737
30.65
US$3,731,762 		121,737 30.65 US$3,731,762
2025-09-08 2025-09-08 PrS Proposed sale
3.5
Crossley Mark

Affiliate
26,463
24.75
US$655,000 		26,463 24.75 US$655,000
2025-09-08 2025-09-08 PrS Proposed sale
3.5
Mark Crossley

affiliate
183,938
24.97
US$4,593,151 		183,938 24.97 US$4,593,151
2025-09-04 2025-09-04 PrS Proposed sale
3.5
Mark Crossley

affiliate
30,000
24.80
US$744,010 		30,000 24.80 US$744,010
2025-08-28 2025-08-28 PrS Proposed sale
3.5
Mark Crossley

affiliate
52,320
24.43
US$1,278,178 		52,320 24.43 US$1,278,178
2024-12-23 2024-12-20 B Purchase
2.9
Robert A. Schriesheim

Non-Executive Director

Executive Director
21,400
11.73
US$251,022 		21,400 11.73 US$251,022
2024-07-30 2024-07-29 B Purchase
2.3
Dr. Keith Humphreys

Non-Executive Director

Executive Director
775
12.67
US$9,822 		775 12.67 US$9,822
2024-07-30 2024-07-26 B Purchase
0.8
Juliet Thompson

Non-Executive Director

Through Timothy Thompson, a closely affiliated person Executive Director
1,925
12.78
US$24,596 		1,925 12.78 US$24,596
2024-07-30 2024-07-26 B Purchase
0.8
Juliet Thompson

Non-Executive Director

Executive Director
1,925
12.78
US$24,596 		1,925 12.78 US$24,596
2024-07-29 2024-07-26 B Purchase
3.2
Mark Stejbach

Non-Executive Director

Executive Director
790
12.63
US$9,978 		790 12.63 US$9,978
2024-07-29 2024-07-26 B Purchase
3.5
Mark Crossley

Chief Executive Officer

Executive Director
7,639
12.75
US$97,397 		7,639 12.75 US$97,397
2024-07-29 2024-07-26 B Purchase Vishal Kalia

Chief Strategy and Global Impact Officer

Officer
4,664
12.71
US$59,279 		4,664 12.71 US$59,279
2024-07-29 2024-07-26 B Purchase
0.8
Jeff Burris

Chief Legal Officer

Officer
760
12.65
US$9,613 		760 12.65 US$9,613
2024-07-26 2024-07-26 B Purchase
3.8
Graham Hetherington

Chair

Director
500
0.02
£10 		500 0.02 £10
2024-07-26 2024-07-26 B Purchase
3.8
Graham Hetherington

Chair

Director
850
0.01
£10 		850 0.01 £10
2024-07-26 2024-07-26 B Purchase Joanna Le Couilliard

Non-Executive Director

Executive Director
1,490
10.06
£14,996 		1,490 10.06 £14,996
2024-05-14 2024-05-09 B Purchase
3.2
Mark Stejbach

Non-Executive Director

Executive Director
550
17.98
US$9,889 		550 17.98 US$9,889
2024-03-18 2024-03-18 S Sale
3.5
Mark Crossley

Chief Executive Officer

Executive Director
10,549
16.17
£170,577 		10,549 16.17 £170,577
2024-03-20 2024-03-15 PrS Proposed sale
2.7
Heidbreder Christian

Officer

Officer
2,090
20.77
US$43,399 		2,090 20.77 US$43,399
2024-03-18 2024-03-15 S Sale
3.5
Mark Crossley

Chief Executive Officer

Executive Director
15,444
16.44
£253,899 		15,444 16.44 £253,899
2024-03-15 2024-03-15 S Sale
2.7
Christian Heidbreder

Chief Scientific Officer

Officer
2,090
20.77
£43,409 		2,090 20.77 £43,409
2024-03-20 2024-03-14 PrS Proposed sale
2.7
Heidbreder Christian

Officer

Officer
15,096
20.75
US$313,231 		15,096 20.75 US$313,231
2024-03-18 2024-03-14 S Sale Richard Simkin

Chief Commercial Officer

Officer
61,285
16.30
£998,946 		61,285 16.30 £998,946
2024-03-18 2024-03-14 S Sale
3.5
Mark Crossley

Chief Executive Officer

Executive Director
91,204
16.30
£1,486,625 		91,204 16.30 £1,486,625
2024-03-15 2024-03-14 S Sale Cindy Cetani

Chief Integrity and Compliance Officer

Officer
66,073
16.21
£1,071,043 		66,073 16.21 £1,071,043
2024-03-15 2024-03-14 S Sale
2.7
Christian Heidbreder

Chief Scientific Officer

Officer
15,096
20.75
£313,242 		15,096 20.75 £313,242
2024-03-14 2024-03-14 PrS Proposed sale
Cetani Cynthia C

Officer

Officer
66,073
21.02
US$1,388,854 		66,073 21.02 US$1,388,854
2024-03-20 2024-03-13 PrS Proposed sale
2.7
Heidbreder Christian

Officer

Officer
6,284
21.06
US$132,362 		6,284 21.06 US$132,362
2024-03-15 2024-03-13 S Sale
2.7
Christian Heidbreder

Chief Scientific Officer

Officer
6,284
21.06
US$132,341 		6,284 21.06 US$132,341
2024-03-13 2024-03-13 S Sale Kathryn Hudson

Company Secretary

Through Paul Hudson, a closely affiliated person
850
16.49
£14,016 		850 16.49 £14,016
2024-03-13 2024-03-13 S Sale Kathryn Hudson

Company Secretary
1,900
16.49
£31,331 		1,900 16.49 £31,331
2024-03-08 2024-03-06 S Sale Richard Simkin

Chief Commercial Officer

Officer
30,000
17.22
£516,600 		30,000 17.22 £516,600
2024-03-06 2024-03-06 S Sale
2.7
Christian Heidbreder

Chief Scientific Officer

Officer
56,722
17.00
£964,274 		56,722 17.00 £964,274
2024-03-06 2024-03-05 S Sale Jon Fogle

Chief Human Resources Officer

Officer
85,868
17.06
£1,464,908 		85,868 17.06 £1,464,908
2024-03-06 2024-03-05 S Sale Richard Simkin

Chief Commercial Officer

Officer
23,974
17.05
£408,757 		23,974 17.05 £408,757
2024-03-06 2024-03-05 S Sale
2.7
Christian Heidbreder

Chief Scientific Officer

Officer
56,445
17.23
£972,547 		56,445 17.23 £972,547
2024-03-06 2024-03-04 S Sale Jon Fogle

Chief Human Resources Officer

Officer
20,437
17.31
£353,764 		20,437 17.31 £353,764
2024-03-06 2024-03-04 S Sale Richard Simkin

Chief Commercial Officer

Officer
18,475
17.35
£320,541 		18,475 17.35 £320,541
2024-03-06 2024-03-04 S Sale
2.7
Christian Heidbreder

Chief Scientific Officer

Officer
21,241
17.34
£368,319 		21,241 17.34 £368,319
2023-12-21 2023-12-20 B Purchase
3.8
Graham Hetherington

Chair

Director
1,743
11.89
£20,724 		1,743 11.89 £20,724
2024-01-25 2023-12-19 B Purchase
3.8
Graham Hetherington

Chair

Director
1,807
11.47
£20,726 		1,807 11.47 £20,726
2023-11-21 2023-11-20 B Purchase
3.8
Graham Hetherington

Chair

Director
2,650
13.50
£35,775 		2,650 13.50 £35,775
2023-11-22 2023-11-17 B Purchase Vishal Kalia

Chief Strategy Officer

Officer
2,730
13.45
£36,718 		2,730 13.45 £36,718
2023-11-20 2023-11-17 B Purchase
3.2
Mark Stejbach

Non-Executive Director

Executive Director
3,000
16.70
US$50,100 		3,000 16.70 US$50,100
2023-11-20 2023-11-17 B Purchase
2.3
Dr. Keith Humphreys

Non-Executive Director

Executive Director
1,200
16.80
US$20,160 		1,200 16.80 US$20,160
2023-05-10 2023-05-05 S Sale Hillel West

Chief Manufacturing and Supply Officer

Officer
110,000
15.70
£1,727,000 		110,000 15.70 £1,727,000
2023-03-24 2023-03-23 S Sale Kathryn Hudson

Company Secretary
2,000
14.08
£28,160 		2,000 14.08 £28,160
2023-03-15 2023-03-14 S Sale Kathryn Hudson

Company Secretary
239,684
14.78
£3,542,530 		239,684 14.78 £3,542,530
2023-03-15 2023-03-14 S Sale Kathryn Hudson

Company Secretary
9,015
14.78
£133,242 		9,015 14.78 £133,242
2023-03-15 2023-03-14 S Sale
2.7
Christian Heidbreder

Chief Scientific Officer

Officer
194,719
14.78
£2,877,947 		194,719 14.78 £2,877,947
2023-03-15 2023-03-14 S Sale Jon Fogle

Chief Human Resources Officer

Officer
93,465
14.78
£1,381,413 		93,465 14.78 £1,381,413
2024-01-25 2023-03-06 B Purchase
3.2
Mark Stejbach

Non-Executive Director

Executive Director
1,300
15.02
£19,530 		1,300 15.02 £19,530
2023-03-08 2023-03-06 B Purchase
3.2
Mark Stejbach

Non-Executive Director

Executive Director
1,400
15.02
£21,032 		1,400 15.02 £21,032
2022-03-15 2022-03-14 S Sale Jon Fogle

Chief Human Resources Officer

Officer
157,844
2.71
£427,757 		157,844 2.71 £427,757
2022-03-08 2022-03-07 S Sale Richard Simkin

Chief Commercial & Strategy Officer

Officer
508,229
2.57
£1,307,673 		508,229 2.57 £1,307,673
2022-03-08 2022-03-07 S Sale
2.7
Christian Heidbreder

Chief Scientific Officer

Officer
569,573
2.57
£1,465,511 		569,573 2.57 £1,465,511
2022-02-18 2022-02-17 S Sale Richard Simkin

Chief Commercial and Strategy Officer

Officer
300,000
2.70
£810,000 		300,000 2.70 £810,000
2021-08-11 2021-08-10 B Purchase
3.2
Mark Stejbach

Non-Executive Director

Executive Director
36,000
1.62
£58,187 		36,000 1.62 £58,187
2021-08-11 2021-08-09 B Purchase
3.2
Mark Stejbach

Non-Executive Director

Executive Director
5,424
1.66
£8,998 		5,424 1.66 £8,998
2021-08-10 2021-08-06 S Sale
1.9
Jerome Lande

Non-Executive Director

Through Scopia Capital Management LP, Scopia Management Inc., a closely affiliated person Executive Director
120,000
1.63
£195,012 		120,000 1.63 £195,012
2021-08-09 2021-08-05 S Sale
1.9
Jerome Lande

Non-Executive Director

Through Scopia Capital Management LP, Scopia Management Inc., a closely affiliated person Executive Director
67,499
1.66
£112,244 		67,499 1.66 £112,244
2021-08-05 2021-08-04 B Purchase
3.8
Graham Hetherington

Chair

Director
29,220
1.71
£50,025 		29,220 1.71 £50,025
Explore more

More insider trading research around Indivior PLC

More insider trades in United Kingdom
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in Europe